| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 2971191 | The Journal of Heart and Lung Transplantation | 2010 | 6 Pages | 
Abstract
												These findings suggest that prostacyclin infusion therapy is problematic and that an opportunity exists to improve safety. The development of standardized treatment guidelines should be considered.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												Martha S. MS, Mark A. PhD, Sandra RN, Susan MS, Fernando MD, Kelly S. MD, Prostacyclin Safety Group Prostacyclin Safety Group, 
											